Naloxone does not reverse the pain-reducing effect of vibratory stimulation

Area of Science:

• Neurology
• Pain Management
• Biomedical Engineering

Background:

• Chronic epicondylitis pain significantly impacts quality of life.
• Vibratory stimulation has shown promise in pain alleviation.
• The role of endogenous opioids in vibratory stimulation's analgesic effect is unclear.

Purpose of the Study:

• To investigate if endogenous opioids mediate pain relief from vibratory stimulation in chronic epicondylitis.
• To determine the effect of naloxone on pain reduction achieved through vibratory stimulation.

Main Methods:

• Fifteen patients with chronic epicondylitis pain received 100 Hz vibratory stimulation.
• Naloxone (a known opioid antagonist) or saline was administered intravenously in a double-blind manner.
• Pain intensity was assessed using a graphic rating scale; peripheral blood flow was monitored in a subset of patients.

Main Results:

• The majority of patients (12/15) did not experience a reversal of pain relief after naloxone administration.
• Only two patients showed reversal of pain alleviation with intravenous naloxone.
• Intramuscular naloxone did not antagonize the pain-reducing effects of vibratory stimulation.

Conclusions:

• Pain relief from 100 Hz vibratory stimulation in chronic epicondylitis is unlikely to be mediated by endogenous opioids.
• Vibratory stimulation may offer a non-opioid pathway for pain management in epicondylitis.